跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TESTOSTERONE ENANTHATE INJECTION, USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TESTOSTERONE ENANTHATE INJECTION, USP
Authorized
STANDARD
TESTOSTERONE ENANTHATE INJECTION, USP
hikma canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
635e6737a1e6bff9
Company
hikma canada limited
Type
Standard
Approval Details
Approval Id
635e6737a1e6bff9
Drug Approval Canada Name
TESTOSTERONE ENANTHATE INJECTION, USP
Product Name
TESTOSTERONE ENANTHATE INJECTION, USP
Status
Marketed
Status Date
2024-01-30
Original Market Date
2024-01-30
Din
02536315
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intramuscular
Schedule
Schedule G (CDSA IV)
Ahfs
68:08.00
Atc Original
G03BA03 TESTOSTERONE
Atc Name
g 03 ba 03
Aig Number
0106403001
Company Name
hikma canada limited
Company Address
5995 Avebury Road, Suite 804, Mississauga, Ontario, Canada, L5R 3P9
Active Ingredients
TESTOSTERONE ENANTHATE
200 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
635e6737a1e6bff9
Type
Standard
Back to Health Canada Approvals